Group One Trading, L.P. Madrigal Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

  • $2.68 Billion
  • Q1 2024

A detailed history of Group One Trading, L.P. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 43,171 shares of MDGL stock, worth $10.2 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
43,171
Previous 191,931 77.51%
Holding current value
$10.2 Million
Previous $44.4 Million 74.04%
% of portfolio
0.43%
Previous 1.42%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$171.37 - $283.23 $25.5 Million - $42.1 Million
-148,760 Reduced 77.51%
43,171 $11.5 Million
Q4 2023

Feb 14, 2024
BUY
$120.4 - $237.13 $14 Million - $27.6 Million
116,243 Added 153.58%
191,931 $44.4 Million
Q3 2023

Nov 09, 2023
BUY
$146.04 - $225.78 $10.7 Million - $16.5 Million
73,004 Added 2719.97%
75,688 $11.1 Million
Q2 2023

Aug 09, 2023
BUY
$203.88 - $312.0 $547,213 - $837,408
2,684 New
2,684 $620,000
Q3 2022

Nov 09, 2022
BUY
$60.57 - $79.51 $543,615 - $713,602
8,975 Added 118.73%
16,534 $1.08 Million
Q2 2022

Aug 11, 2022
BUY
$58.04 - $100.2 $438,724 - $757,411
7,559 New
7,559 $541,000
Q4 2021

Feb 11, 2022
SELL
$72.34 - $95.09 $89,195 - $117,245
-1,233 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$78.35 - $105.02 $7,834 - $10,502
-100 Reduced 7.5%
1,233 $98,000
Q2 2021

Aug 10, 2021
BUY
$97.2 - $137.59 $38,880 - $55,036
400 Added 42.87%
1,333 $130,000
Q1 2021

May 12, 2021
SELL
$108.54 - $125.2 $253,115 - $291,966
-2,332 Reduced 71.42%
933 $109,000
Q4 2020

Feb 10, 2021
SELL
$110.06 - $133.7 $40,942 - $49,736
-372 Reduced 10.23%
3,265 $363,000
Q3 2020

Nov 12, 2020
BUY
$99.78 - $124.21 $349,230 - $434,735
3,500 Added 2554.74%
3,637 $432,000
Q2 2020

Aug 13, 2020
BUY
$60.13 - $125.71 $8,237 - $17,222
137 New
137 $16,000
Q4 2019

Feb 10, 2020
SELL
$84.28 - $118.5 $140,410 - $197,421
-1,666 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$84.4 - $106.53 $75,960 - $95,877
900 Added 117.49%
1,666 $144,000
Q2 2019

Aug 09, 2019
BUY
$91.13 - $142.5 $69,167 - $108,157
759 Added 10842.86%
766 $80,000
Q1 2019

May 13, 2019
BUY
$103.48 - $143.84 $724 - $1,006
7 New
7 $1,000

Others Institutions Holding MDGL

# of Institutions
313
Shares Held
20M
Call Options Held
824K
Put Options Held
1.04M
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $4.04B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email